PAP
CRL icon

Persistent Asset Partners’s Charles River Laboratories CRL Stock Holding History

Persistent Asset Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Sell
1,177
-1,466
-55% -$261K 0.08% 176
2026
Q1 		$456K Buy
2,643
+544
+26% +$101K 0.17% 119
2025
Q4 		$419K Buy
+2,099
New +$381K 0.19% 147

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Persistent Asset Partners's CRL Position: Q2 2026 in Review

Persistent Asset Partners reduced its Charles River Laboratories (CRL) stake by 55% in Q2 2026, selling an estimated $261K and leaving 1,177 shares worth $267K. The position accounts for 0.08% of the portfolio, ranked #176.

Persistent Asset Partners first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. The position peaked at $456K in Q1 2026. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Persistent Asset Partners held 1,177 shares of Charles River Laboratories worth $267K as of Q2 2026.
  • Persistent Asset Partners sold 1,466 Charles River Laboratories shares in Q2 2026, an estimated $261K.
  • Charles River Laboratories made up 0.08% of Persistent Asset Partners's portfolio in Q2 2026, its #176 holding.
  • Persistent Asset Partners first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's Charles River Laboratories position peaked at $456K in Q1 2026.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.